The metabolic fluxes ofcis-5-enoyl-CoAs through the ,8-oxidation cycle were studied in solubilized rat liver mitochondrial samples and compared with saturated acyl-CoAs of equal chain length. These studies were accomplished using either spectrophotometric assay of enzyme activities and/or the analysis of metabolites and precursors using a gas chromatographic method after conversion of CoA esters into their free acids. Cis-5-enoyl-CoAs were dehydrogenated by acyl-CoA oxidase or acyl-CoA dehydrogenases at significantly lower rates (10-44 %) than saturated acylCoAs. However, enoyl-CoA hydratase hydrated trans-2-cis-5-enoyl-CoA at a faster rate (at least 1.5-fold) than trans-2-enoylCoA. The combined activities of 3-hydroxyacyl-CoA dehydrogenase and 3-ketoacyl-CoA thiolase for 3-hydroxy-cis-5-enoylCoAs derived from cis-5-enoyl-CoAs were less than 40 % of the
INTRODUCTION
Fatty acids with odd-numbered double bonds are thought to be metabolized by ,-oxidation cycles to cis-5-enoyl-CoA, compound (I), which continues to cis-3-enoyl-CoA, compound (IV), via one more cycle ( Figure 1 ). A3,A2-Enoyl-CoA isomerase then converts cis-3-enoyl-CoA into trans-2-enoyl-CoA and back to the regular f-oxidation cycles. This is termed the conventional pathway here. Recently, we described a new pathway for the metabolism of cis-5 unsaturated fatty acids [1] . This pathway requires NADPH as cofactor for the reduction of double -bonds. Most recent data have indicated that this pathway is via the dehydrogenation of cis-5-enoyl-CoA to trans-2-cis-5-dienoylCoA, compound (II), which is isomerized to A3A6-dienoyl-CoA, compound (III-R), catalysed by A3,A2-enoyl-CoA isomerase or a peroxisomal trifunctional enzyme [2, 3] . A new isomerase, AA35-trans-2-trans-4-dienoyl-CoA isomerase, then converts A3A5-dienoyl-CoA into trans-2-trans-4-dienoyl-CoA, compound (IV-R), which is reduced by 2,4-dienoyl-CoA reductase with NADPH as cofactor to trans-3-enoyl-CoA. Another isomerization catalysed by A3,A2-enoyl-CoA isomerase converts trans-3-enoyl-CoA into trans-2-enoyl-CoA and back to the regular fatty acid ,f-oxidation cycle [2] . This is here referred to-as the reduction pathway. The new enzyme, A3A5-trans-2-trans-4-dienoyl-CoA isomerase, has been isolated and purified to apparent homogeneity [3, 4] . Although it is evident that rat liver mitochondria are capable of metabolizing cis-5-enoyl-CoA via the reduction pathway, the relative contribution of this pathway to the overall metabolic flux of cis-5-enoyl-CoA is not known. The other question to be answered is whether the conventional isomerase-mediated pathactivity for the corresponding 3-hydroxyacyl-CoAs prepared from saturated acyl-CoAs. Rat liver mitochondrial ,-oxidation enzymes were capable of metabolizing cis-5-enoyl-CoA via one cycle of f-oxidation to cis-3-enoyl-CoA with two less carbons. However, the overall rates of one cycle of f-oxidation, as determined with stable-isotope-labelled tracer, was only 15-25 %, for cis-5-enoyl-CoA, of that for saturated acyl-CoA. In the presence of NADPH, the metabolism of cis-5-enoyl-CoAs was switched to the reduction pathway. Therefore, in intact liver mitochondria, where the NADPH/NADP+ and NAD+/NADH ratios are high, the predominant pathway for the metabolism of cis-5-enoyl-CoAs could be reduction via 2,4-dienoyl-CoA reductase after isomerization of A3A5-dienoyl-CoA to trans-2-trans-4-dienoyl-CoA.
way exists in mitochondria. Although the isomerization of cis-3-enoyl-CoA to trans-2-enoyl-CoA has been demonstrated in rat liver mitochondria [5] , the metabolism of cis-5-enoyl-CoA to cis-3-enoyl-CoA via one cycle of fl-oxidation in the conventional pathway has never been documented. We found that the metabolism of cis-5-enoyl-CoA in solubilized rat liver mitochondria was extremely slow and no metabolites from a complete cycle of fl-oxidation could be detected [1] . In contrast, the saturated acylCoAs readily produced metabolites from one to three cycles of ,6-oxidation under identical conditions.
In this investigation, we compare the metabolic flux through the f-oxidation cycle of cis-5-enoyl-CoA with that of the saturated acyl-CoA of equal chain length. We used spectrophotometric assay of enzyme activities and/or analysis of metabolites using gas chromatography after conversion of CoA esters into their free acids. The maximal catalytic activities of the f,-oxidation-cycle enzymes, i.e. acyl-CoA oxidase, acyl-CoA dehydrogenase, enoyl-CoA hydratase, 3-hydroxyacyl-CoA dehydrogenase and 3-ketoacyl-CoA thiolase, toward cis-5-enoyl-CoA were measured. In addition, the overall rate of the one cycle of fl-oxidation using cis-5-dodecenoyl-CoA as substrate in solubilized rat liver mitochondria was compared with dodecanoyl-CoA using a novel stable-isotope tracer technique. The purpose of these studies was to characterize the steps that account for the significantly lower metabolic rate offurther oxidation of cis-5-enoylCoA through the f-oxidation cycle. Reconstitution experiments with purified enzymes coupled with gas-chromatographic and gaschromatographic-mass-spectrometric analysis were used to investigate the conversion of cis-5-enoyl-CoA into cis-3-enoyl-CoA via one cycle of fl-oxidation in solubilized rat liver mitochondria.
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MATERIALS AND METHODS
Reagents and chemicals Cis-5-decenoic, cis-5-dodecenoic and cis-5-tetradecenoic acids were synthesized as previously described [6] . Trans-2-trans-4-decadienoic acid was synthesized by the oxidation of trans-2-trans-4-decadienal (Aldrich) with Jones' reagent. Cis-3-decenoic acid was prepared by the oxidation and reduction of cis-3-decyn-1-ol (Farchan) with Jones' reagent in acetone [6] . Acyl-CoA esters were prepared by the modified mixed-anhydride method with ethyl chloroformate and triethylamine in tetrahydrofuran [7] . Their concentrations were determined by Ellman's procedure [8] . Acyl-CoA oxidase (from Arthrobacter sp.) was purchased from Boehringer-Mannheim (Indianapolis, IN, U.S.A.). Crotonase (from porcine heart) and 3-hydroxyacyl-CoA dehydrogenase (from porcine heart) were obtained from Sigma. Dodecanoyl-CoA and decanoyl-CoA were purchased from Sigma. Tetradecanoyl-CoA was synthesized by the mixed-anhydride method [7] . NADI, NADPH and CoA were obtained from Assay of enoyl-CoA hydratase
As the substrates, trans-2-cis-5-dienoyl-CoAs, were not available by chemical synthesis, the activity of enoyl-CoA hydratase, i.e. hydration of trans-2-cis-5-dienoyl-CoA and trans-2-enoyl-CoA to their 3-hydroxy metabolites, was studied using a gas-chromatographic method. The substrates were generated by dehydrogenation of cis-5-dodecenoyl-CoA and dodecanoyl-CoA with acyl-CoA oxidase (0.5 unit/ml). Purified crotonase (0.4 unit) was then added and the mixture was incubated at 37°C for 5 min. The production of 3-hydroxy metabolite was determined by gaschromatographic analysis after extraction ofhydrolysed products and derivatization.
Measurement of 3-hydroxyacyl-CoA dehydrogenase activity
Measurement of the forward reaction as described by He et (120 /tl/ml of incubation mixture).
Metabolic profiling of the incubation mixture
An aliquot (1 ml) of the incubation mixture, pretreated with KOH, was mixed with internal standard (20 ,tg of pentadecanoic acid) and hydrolysed at room temperature for 50 min. The mixture was acidified and extracted with ethyl acetate/diethyl ether (1:1). After conversion into trimethylsilyl derivatives, the sample was analysed with a dual-capillary column gas chromatograph (model 5890; Hewlett-Packard, Avondale, PA, U.S.A.), using a bonded dimethylpolysiloxane phase (SPB-1 from Supelco, Bellefonte, PA, U.S.A.) and a bonded 35 % diphenyl/65 % dimethylpolysiloxane phase (SPB-35)-fused silica capillary column (also available from Supelco by custom order). The initial column temperature was 60°C and increased at 4°C/min to 250°C with a 50: 1 split injection ratio. Quantification was based on the relative peak area to internal standard. The amount of metabolite was calculated as the weight equivalent to that of internal standard on the basis of area ratio.
A Hewlett-Packard 5985B gas chromatograph/mass spectrometer was used for metabolite identification and determination of isotope enrichment. A shorter (12.5 m) fused silica capillary column (SPB-1) was used with the same temperature program as described for gas chromatography. Electron-impact (70 eV) ionization and repetitive-scanning (300 atomic mass units/s) from m/z 49 to 550 was used to obtain mass spectra. The criteria for identification of compounds were that the retention times on both gas-chromatographic columns and the mass spectrum were identical with those obtained with authentic samples.
Selected ion-monitoring determination of isotopic enrichment in metabolites
Derivatized samples were separated through an SPB-1 capillary gas-chromatographic column as described above. The column temperature was 140°C initially, then it was increased at a rate of 4°C/min after injection. Chromatographic effluent was monitored at m/z 229, 231 and 233 at a dwell time of 100 ms for each ion for decanoic acids; m/z 233, 235 and 237 were used for 3-hydroxydecanoic and 3-hydroxydodecanoic acids. Peaks areas were determined and normalized to the peak area of unlabelled ion (taken as 100). Metabolites produced by the incubation of unlabelled substrate were also analysed to obtain natural abundance isotope enrichments. For the calculation of percentage enrichment of each labelled species, the relative peak areas were corrected for the contribution of natural isotope abundance by a technique described previously [11] .
RESULTS
Dehydrogenation of cis-5-enoyl-CoA by acyl-CoA dehydrogenase and acyl-CoA oxidase 3-Hydroxyacyl-CoA dehydrogenase activity toward 3-hydroxy-cis-5-enoyl-CoAs
Rat liver mitochondrial 3-hydroxyacyl-CoA dehydrogenase activity toward 3-hydroxy-cis-5-decenoyl-CoA, 3-hydroxy-cis-5-dodecenoyl-CoA and 3-hydroxy-cis-5-tetradecenoyl-CoA was measured and compared with the activity toward their saturated counterparts. The data are shown in Table 1 . In all three substrates, the rates with the 3-hydroxy-cis-5-substrates were significantly lower than with their saturated counterparts: 61 + 9 % for 3-hydroxy-cis-5-tetradecenoyl-CoA, 80 + 10 % for 3-hydroxy-cis-5-dodecenoyl-CoA and 31+50% for 3-hydroxycis-5-decenoyl-CoA relative to their individual saturated counterparts. The activities of commercial porcine heart 3-hydroxyacylCoA dehydrogenase were 24 % for 3-hydroxy-cis-5-tetradecenoyl-CoA, 15 % for 3-hydroxy-cis-5-dodecenoyl-CoA and 24 % for 3-hydroxy-cis-5-decenoyl-CoA compared with their saturated counterparts.
Conversion of 3-hydroxy-cis-5-enoyl-CoA into cis-3-enoyl-CoA by one cycle of 11-oxidation
The combined activity of 3-hydroxyacyl-CoA dehydrogenase and 3-ketoacyl-CoA thiolase was studied by measuring the dodecenoate. The metabolites produced were 27 #M decanoate and 11 1sM cis-3-decenoate in this experiment. 3-Hydroxy-cis-5-dodecenoyl-CoA was produced by incubation of cis-5-dodecenoyl-CoA with acyl-CoA oxidase (0.5 unit) and crotonase (0.56 unit) in 20 mM phosphate buffer, pH 8, for 10 min. Partially purified rat liver 3-ketoacyl-CoA thiolase (33 m-units using 3-oxo-octanoyl-CoA as substrate), porcine heart 3-hydroxyacyl-CoA dehydrogenase (1.2 units), CoA (0.3 mM) and NAD+ (2 mM) were then added and incubation was continued for an additional 2 min. The mixtures were hydrolysed and analysed by dual-column capillary gas chromatography. The conditions for the 3-hydroxydodecanoyl-CoA experiment were similar to the above conditions except that acyl-CoA oxidase was not added.
production of cis-3-enoyl-CoA from 3-hydroxy-cis-5-enoyl-CoA. In these experiments, bovine liver crotonase was used to generate 3-hydroxy-cis-5-dodecenoyl-CoA from trans-2-cis-5-dodecadienoyl-CoA produced from cis-5-dodecenoyl-CoA and acyl-CoA oxidase. To this mixture was then added 3-hydroxyacyl-CoA dehydrogenase and partially purified rat liver general 3-ketoacylCoA thiolase. The results are shown in Figure 2 . Cis-3-decenoate was formed. Therefore enzymes from rat liver mitochondria are capable of metabolizing cis-5-enoyl-CoA to cis-3-enoyl-CoA by the conventional isomerase pathway via one cycle of ,-oxidation. The quantitative aspect of this conversion was compared with similar studies performed on 3-hydroxydodecanoyl-CoA. Decanoate was produced faster than the corresponding reaction to cis-3-decenoate with a product ratio, after 2 min incubation, of Figure 3 . The time course of the production of metabolites is shown in ,f-oxidation could be found.
In comparison, decanoyl-CoA was metabolized to 3-hydroxydecanoate and 3-hydroxyoctanoate. The latter metabolite was apparently derived from 3-hydroxydecanoyl-CoA after one complete ,6-oxidation cycle. M) , a minor amount of decanoate, trans-2-decanoate, trans-2-dodecanoate and unchanged dodecanoate (total 22 ,uM). In this study, the M+4 enrichment of 3-hydroxydodecenoate was 100 %, the M+ 2 enrichment of 3-hydroxydecanoate was 98 %, and M + 2 enrichment of decanoate was 970%. From these isotope-enrichment experiments, the product-precursor relationship between dodecanoyl-CoA and 3-hydroxydodecanoate, 3-hydroxydecanoate and decanoate was established. The small dilution of isotope enrichments probably resulted from the entry of unlabelled decanoate from tissue fatty acids.
The co-incubation of equal amounts of [1,2,3,4-13C4]dodecanoyl-CoA and cis-5-dodecanoyl-CoA (77,M each) yielded metabolites with a slight dilution of 3-hydroxydodecanoate (99 % M+4). The M+O enrichment of 3-hydroxydecanoate ranged from 3 to 15 % (11 ± 5 %) for incubation times of 2-10 min. In these experiments, the conversion of 3-hydroxy-cis-5-dodecenoylCoA into cis-3-decenoyl-CoA, then to 3-hydroxydecanoyl-CoA, was not dependent on the substrate concentration of precursor.
On the basis of these data, the fl-oxidation rate of the first complete cycle for cis-5-dodecenoyl-CoA was only 11_5 % of that for dodecanoyl-CoA. Decanoate produced in these experi- test). Therefore, a high NAD+/NADH ratio increased the conventional pathway, but the overall flux was still significantly below that for saturated acyl-CoA. When NADPH (0.7 mM) was included in the incubation mixture, the M+ O enrichment in 3-hydroxydodecanoate increased with incubation time as shown in Figure 4 . The concentration of 3-hydroxy-cis-5-dodecenoate decreased from 40 ,uM at 2 min to 9 ,uM at 15 min of incubation and the concentration of 3-hydroxydodecanoate stayed constant at 71+3 ,uM. These data indicate that the reduction pathway converted 3-hydroxycis-5-dodecenoyl-CoA into 3-hydroxydodecanoyl-CoA. In contrast with the incubation without NADPH (Table 2) , the concentration of trans-2-trans-4-dodecadienoate did not change significantly, staying at 2±1+ M. The incubation with both NADPH (0.7 mM) and NAD+ (1.5 mM) gave the same results as the experiments with NADPH alone.
DISCUSSION
In this study, we have shown that cis-5-enoyl-CoAs were dehydrogenated at lower rates than the corresponding saturated acyl-CoAs. The hydration of trans-2-cis-5-enoyl-CoA to 3-hydroxy-cis-5-enoyl-CoA mediated by crotonase was faster than the same reaction using trans-2-enoyl-CoA as substrate. The dehydrogenation of 3-hydroxy-cis-5-enoyl-CoA and the cleavage to form cis-3-enoyl-CoA with two less carbons was also shown to be slower (33 %) than with the corresponding saturated acylCoA. The decrease in the rate of this conversion could be due, at least in part, to the 3-hydroxyacyl-CoA dehydrogenase, as enzyme assay revealed a reduced activity of this enzyme with 3-hydroxy-cis-5-enoyl-CoAs as substrates. However, even with these reduced enzyme activities toward cis-5-enoyl-CoA and intermediates, the mitochondrial enzymes were capable of metabolizing cis-5-enoyl-CoA to cis-3-enoyl-CoA via one cycle of fioxidation in the absence of the competing reduction pathway.
However, the rate of this overall conversion was much slower than that of the corresponding saturated acyl-CoA. The failure to detect metabolites in previous studies was due to the rate of production of these metabolites being too low to permit their accumulation.
The branching point for the two pathways, i.e. reduction and conventional, is trans-2-cis-5-dienoyl-CoA (Figure 1) . The reversible hydration of this intermediate by enoyl-CoA hydratase to 3-hydroxy-cis-5-enoyl-CoA would potentially channel the oxidation towards the conventional pathway. On the other hand, the irreversible isomerization of trans-2-cis-5-dienoyl-CoA to A3A5-dienoyl-CoA [4] would favour the reduction pathway. However, enoyl-CoA hydratase is not a rate-limiting enzyme in fatty acid fl-oxidation. The metabolic fluxes appear to be determined by the step(s) after the formation of 3-hydroxyacylCoA, i.e. 3-hydroxyacyl-CoA dehydrogenase and 3-ketoacylCoA thiolase [12] . For cis-5-enoyl-CoA, these two steps have been shown in this investigation to operate at no more than onethird of the activity observed for saturated acyl-CoA. The overall pathway, as measured by stable-isotope labelling, indicated that cis-5-enoyl-CoAs were metabolized by one cycle of f-oxidation at a rate that was less than 15-25 % of that for saturated acylCoA.
In the presence of the NADPH, the metabolism of cis-5-enoylCoA switched to the reduction pathway. Trans-2-trans-4-dodecadienoate as CoA ester, which normally accumulated in the absence of NADPH (Table 2) , did not accumulate and was converted into 3-hydroxydodecanoyl-CoA, through trans-3-enoyl-CoA and trans-2-enoyl-CoA. 3-Hydroxydodecanoyl-CoA was then metabolized via the ,-oxidation pathway to decanoylCoA and 3-hydroxydecanoyl-CoA. As shown in Figure 4 , the M+ 0 enrichments of decanoate stayed at 20 %. This indicated that 20 % of decanoate was derived from cis-5-dodecenoyl-CoA by the reduction pathway, as the conventional pathway does not produce decanoate. The rest of the decanoate (80 %) with M+ 2 label was derived from the fl-oxidation of M + 4 labelled dodecanoyl-CoA. Likewise, unlabelled 3-hydroxydodecanoate was produced from cis-5-dodecenoyl-CoA by the reduction pathway. However, unlabelled (M+O) 3-hydroxydecanoate can be produced by either the conventional or the reduction pathway. After 8 min ofincubation, the M+ 0 content of 3-hydroxydodecanoate, 3-hydroxydecanoate and decanoate became equal and showed product-precursor relationship. This is consistent with the reduction pathway being the major route of metabolism in the presence of NADPH. In these studies, the smaller contribution of unlabelled decanoate and 3-hydroxydodecanoate to the overall pools of these metabolites produced by the reduction of an equal concentration of cis-5-dodecenoyl-CoA can be rationalized by the lower production rates. The sequence for dodecanoyl-CoA leading to 3-hydroxydodecanoate required only two steps, i.e. dehydrogenation and hydration. In comparison, the sequence for cis-5-dodecenoyl-CoA required six to eight steps, i.e. dehydrogenation, isomerization, isomerization, reduction, isomerization and hydration, or dehydrogenation, hydration, dehydration, isomerization, isomerization, reduction, isomerization and hydration. At early incubation times (Figure 4) , the M+ 0 enrichments of decanoate and 3-hydroxydecanoate were significantly higher than that of 3-hydroxydodecanoate. This is probably caused by the much larger 3-hydroxydodecanoate pool; therefore it took longer for this pool to be equilibrated. Such a relationship is consistent with the 'leaking hosepipe' model proposed by Stanley and Tubbs [13] .
In intact mitochondria, the rates of oxidation of fatty acids containing even-and odd-numbered double bonds have been shown to be comparable with those of saturated fatty acids [14] .
In the present study, the ,8-oxidation rate of cis-5-enoyl-CoA in solubilized mitochondria, which lacked the reduction pathway because of a low NADPH/NADP+ ratio [15] , was shown to be significantly lower than that of the corresponding saturated fatty acids. Therefore it is likely that the reduction pathway for unsaturated fatty acids with odd-numbered double bonds is important in intact mitochondria to compensate for the decreased conventional f-oxidation pathway. Rat liver mitochondria have an NAD+/NADH ratio of 20 and an NADPH/NADP+ ratio of 200 [15] . The high intramitochondrial NADPH/NADP+ ratio is maintained by isocitrate dehydrogenase, glutamate dehydrogenase and energy-dependent nicotinamide nucleotide transhydrogenase [15] . It is possible that the reduction pathway of unsaturated fatty acids accounts for the requirement for high transhydrogenase and isocitrate dehydrogenase activity in heart cells despite a lack of major NADPH-requiring synthetic processes in these sites. Heart cells use fatty acids as their major metabolic fuel.
